-+ 0.00%
-+ 0.00%
-+ 0.00%

Zentalis Pharmaceuticals FY2025 targets ASPENOVA Phase 3 trial start in 1H 2026; cash climbs to $246 million

Reuters·03/26/2026 20:25:20

Please log in to view news